Medtronic plc (MDT) operating KPIs
MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 19/303% below fair value
$96.54−0.57 (-0.59%)
Close on Oct 30, 2026Market cap $123.49BP/E 23.7Yield 2.94%
Medtronic cardiovascular — Segment R&D Expense ($M) ($M)
Medtronic Form 10-K/10-Q Segment Footnote XBRL (ASU 2023-07)
Latest, FY2026
1,136
Period ended Apr 30, 2026
Change on a year earlier
+11.4%
1,020 in FY2025
History
4 years
Since FY2023
Sources
2
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Cardiovascular — Segment R&D Expense ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2026 | Apr 30, 2026 | 1,136 | +11.4% | Medtronic Form 10-K — FY2026 (filed 2026-06-18) ↗ |
| FY2025 | Apr 30, 2025 | 1,020 | +2.9% | Medtronic Form 10-K — FY2026 (filed 2026-06-18) ↗ |
| FY2024 | Apr 30, 2024 | 991 | +21.6% | Medtronic Form 10-K — FY2026 (filed 2026-06-18) ↗ |
| FY2023 | Apr 30, 2023 | 815 | – | Medtronic Form 10-K — FY2025 (filed 2025-06-20) ↗ |
Breakdown
What makes up cardiovascular — segment r&d expense ($m)
Cite this data
StockData. (2026). Medtronic Cardiovascular — Segment R&D Expense ($M) ($M), annual FY2023–FY2026 [Data set]. Compiled from Medtronic SEC filings and investor materials. https://stockdatahq.com/stocks/mdt/kpis/seg-rd-cv
See every metric in the Medtronic KPI table. Data updated Oct 31, 2026.